Orphan Drug Designations and the Pipeline for SWS Therapeutics
Data Bridge Market Research confirms that the global Sturge-Weber Syndrome (SWS) Treatment Industry is poised for robust expansion, driven by increasing diagnostic rates, significant advancements in laser and surgical treatments, and a growing focus on rare neurocutaneous disorders. The market’s upward trajectory underscores the persistent, unmet need for specialized therapeutic...
0 Comments
0 Shares
70 Views